Biocodex at a glance

Since 1953, Biocodex teams have been passionately committed to a single mission: providing innovative healthcare solutions to women, men and children worldwide. Present in 115 countries, Biocodex’s 1,664 employees are committed to serving millions of patients around the world. We apply our expertise to developing and marketing a wide range of products to meet patient needs, focusing on three pillars: Microbiota care, women’s health and orphan diseases.

Biocodex key figures

An international pharmaceutical company serving patients in 115 countries
€ 501M in revenue 2022
3 key areas of expertise: microbiota care, women’s health and orphan diseases.
Founded in 1953 to market Saccharomyces boulardii CNCM I-745®, the world’s first probiotic yeast strain for human medicine
More than 1,664 employees of 30 nationalities
3 industrial facilities in France and Morocco
1 R&D center in France
Subsidiaries in 17 countries
Presence in 100 countries through our distributors
An investor in 4 start-ups specialized in innovative health solutions

December 31, 2022 figures

Want to know more?

About Us

Our development

Headquartered in France, Biocodex offers health solutions to patients in more than 115 countries through 17 subsidiaries and a network of long-term partners worldwide.

Board meeting room with a large oval white table and black chairs around it with no attendees.

About Us

Our governance

Biocodex has two governing bodies: a Board of Directors and an Executive Committee. Jean-Marie Lefèvre is Chairman of the Board of Directors, while Nicolas Coudurier is our Chief Executive Officer.

Main entrance of Biocodex industrial facilities in Beauvais (Oise, France.

Our Science

Our facilities

Biocodex operates three manufacturing facilities in France and Morocco in compliance with the highest standards to guarantee product quality and safety.